Published in Hepatitis Weekly, February 20th, 2006
"HIV-infected patients have weak responses to vaccines and may require revised immunization regimens. We investigated the safety and immunogenicity of 2 doses of HAV vaccine followed by a booster dose in HIV-infected children receiving stable HAART," wrote A. Weinberg and colleagues, University of Colorado Health Sciences Center.
"A total of 235 children with CD4+ T cell percentages...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.